Summary
- Profile Type
- Business Offer
- POD Reference
- BOES20240213022
- Term of Validity
- 25 March 2024 - 25 March 2026
- Company's Country
- Spain
- Type of partnership
- Commercial agreement
- Targeted Countries
- Canada
- United States
- United Kingdom
- Italy
- Portugal
- United Arab Emirates
- Germany
- France
- Poland
- Switzerland
- Norway
- Netherlands
- Sweden
Contact the EEN partner nearest to you for more information.
Find my local partner
General information
- Short Summary
- The Spanish research support foundation combines its scientific activities and research projects collaborative approach with the provision of clinical research support services. It offers its expertise and collaboration network to partners willing to initiate, redesign or enlarge their clinicial trials focused in several therapeutic areas and diseases (see full description). Collaboration is sought under commercial with technical assistance or r&d agreements.
- Full Description
-
As an experience life science research services provision entity, the Spanish foundation activities catalogue as those of a unique CRO. With over 26 years of experience, and founded under a three pillars basis, drug research, scientific training and services provision, it has already reach a maturity stage for its standard process. With quality certifications and sound practices set since 2005, the foundation its now under a digital transition stage, carried out in order to ameliorate its multidisciplinary teamwork processes, and focused on delivering better services to its clients.
Supported by one of the largest groups of clinical pharmacologists in the Iberian Peninsula, with a strong academic background, and a wide network of collaborators (clinical researchers, public and private hospitals as well as clinical centers across Spain and Portugal), they are willing to reach new partners abroad, offering its research support services and their research experience in areas as neurodegenerative, pulmonary diseases or pain treatments.
Their research support services comprises activities from kick off to pharmacology surveillance stages of the standard clinical trial stages, developed in a hybrid and collaborative way, seeking adaptability regarding agility and control requirements from clients. They can get involved in: the design of the project, drafting of protocols, start-up, monitoring, design of the CRF, clinical data management, preparation of final results reports, statistical analysis, and texts translations.
Their activities comply with the ethical principles that have their origin in the Declaration of Helsinki and with the Standards of Good Clinical Practice (GCP) and current Legislation; and
since 2017, they are certified under ISO 9001: 2015 (Certification for Quality Management Systems, which includes the Coordination, Management and Monitoring of Clinical Trials).
Primary therapeutic areas of interest for collaboration are:
Cardiovascular, diseases of the blood and blood-forming organs; immune disorders, Diseases of the eye, Diseases of the nervous system, Endocrine, nutritional and metabolic diseases, Genitourinary system, Mental and behavioral disorders, Musculoskeletal system and connective tissue, Neoplasms / cancer / oncology, Respiratory system, Skin and subcutaneous tissue.
.
Already engaged in its first international collaboration steps, the entity wants to expand its network of collaborators across Europe. Collaborative commercial with technical assistance or r&d agreements are offered for innovative life science partners related with drug discovery processes and clinical trials activities. - Advantages and Innovations
-
Life sciences contract research sector is comprised of different agents and roles, full service CROs with ample experience and solid supplier and client networks at Spanish level are few.
Following digitalization and sustainabilty drivers the Spanish CRO keeps focused in providing value to its client thanks to organizational processes' innovation in order to take every clinical trial on time, as cost-effective as possible and with the highest quality, guaranteeing their success.
Performance advantages are to be found in:
Multidisciplinary Team: Our team consists of multidisciplinary experts, which can contribute diverse perspectives and skills.
Client Focus: We are focused on client satisfaction, which can enhance collaboration and ensure project success.
Access to Clinical Pharmacologists: Having support from one of the largest groups of clinical pharmacologists in the Iberian Peninsula.
Strong Network: Through our foundation's relationships with the Spanish academic scenario, particularly the Autonomous University of Madrid (UAM), and access to a wide network of key clinical researchers, hospitals and clinical centers across Spain and Portugal, providing extensive resources and services.
End-to-End Support: We can provide comprehensive support throughout the entire research process, from project design to final results reporting and translation.
Experience Across Therapeutic Areas: With experience in key indications such as oncology, neurodegenerative diseases, pneumology, dermatology, and others, you offer a broad understanding of various pathologies and clinical needs.
Focused on a Patient’s Approach: Prioritizing patient well-being and safety demonstrates a commitment to ethical research practices.
Clinical Research Expertise: Our Clinical Research Department collaborates with the pharmaceutical industry on clinical studies, providing valuable insight and support for new drug research and medical device development. - Technical Specification or Expertise Sought
- Partners with experience and activities in drug delivery research or clinical trials already engaged in new developments regarding the therapeutic areas of interest.
- Stage of Development
- Already on the market
- Sustainable Development Goals
- Goal 3: Good Health and Well-being
- Goal 5: Gender Equality
- Goal 4: Quality Education
- IPR status
- No IPR applied
Partner Sought
- Expected Role of a Partner
- Expected partners should preferably come from the Life sciences area, drug research or medtech development agents as: startups, biotech companies, CROs , drug manufacturers, and other drug research and drug delivery agents (consultants, innovation agents). Parnters roles should be related with activities from preclinical to pharma-surveillance trials.
- Type and Size of Partner
- Other
- Type of partnership
- Commercial agreement
Dissemination
- Technology keywords
- 06001002 - Clinical Research, Trials
- 06005003 - Health information management
- 09006001 - Quality Standards
- Market keywords
- 05007007 - Other medical/health related (not elsewhere classified)
- 05005022 - Other clinical medicine
- Sector Groups Involved
- Health
- Targeted countries
- Canada
- United States
- United Kingdom
- Italy
- Portugal
- United Arab Emirates
- Germany
- France
- Poland
- Switzerland
- Norway
- Netherlands
- Sweden